Table 9.
Chickpea peptides and hydrolysate having antidiabetic properties.
Peptide source | Preparation method | Obtained peptides | In vitro, in vivo antidiabetic property | References |
---|---|---|---|---|
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | GKGSGAF | Inhibit DPP-IV | (84) |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | RASAAGGGGGGVSSR | Inhibit DPP-IV | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | QNPLSSAAPTGAGKPY | Inhibit DPP-IV | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | AMMELGWSTSGEFLL | Inhibit DPP-IV | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | TRGTGGR | Inhibit DPP-IV | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | LLGELCGSGNTVVEL | Inhibit alpha-glucosidase, DPP-IV, DPP-III | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | GKAAPGSGGGTKA | alpha-glucosidase, DPP-IV, DPP-III | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | GLTQGASLAGSGAPSPLF | Inhibit alpha-glucosidase, DPP-IV, DPP-III | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | KSGGGGGGTAVT | DPP-IV, DPP-III | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | NKKSGAGGGSGAGKGGVA | Inhibit DPP-IV | |
Chickpea protein hydrolysate | Bromelain enzyme, LC-ESI/MS | KMTAGSGVT | Inhibit DPP-IV | |
Germinated chickpea isolate protein | Papain or ficin enzyme (LC-ESI-MS/MS) | SPGAGKG, GLAR, and STSA | In vivo inhibition of DPP-IV and α-glucosidase | (91) |
Chickpea protein hydrolysate | Pepsin-pancreatin, LC-MSMS | SPKGAGF | dipeptidyl peptidase IV (DPPIV) inhibition | (92) |
Chickpea protein hydrolysate | Pepsin-pancreatin, LC-MSMS | NGPGPA | dipeptidyl peptidase IV (DPPIV) inhibition | |
Chickpea protein hydrolysate | Pepsin-pancreatin, LC-MSMS | GKGSAT | dipeptidyl peptidase IV (DPPIV) inhibition | |
Chickpea protein hydrolysate | Pepsin-pancreatin, LC-MSMS | SPKGAGF | dipeptidyl peptidase IV (DPPIV) inhibition |